184 related articles for article (PubMed ID: 38776611)
21. Clinical and economic outcomes in patients at risk of venous thromboembolism receiving appropriate enoxaparin or unfractionated heparin prophylaxis.
Amin AN; Lin J; Lenhart G; Schulman KL
Thromb Haemost; 2009 Aug; 102(2):321-6. PubMed ID: 19652883
[TBL] [Abstract][Full Text] [Related]
22. Underutilization of anticoagulant for venous thromboembolism prophylaxis in three hospitals in Jakarta.
Atmakusuma TD; Tambunan KL; Sukrisman L; Effendi S; Rachman A; Setiawati A; Rinaldi I; Mulansari NA; Rajabto W; Nasution SA; Muhadi ; Aninditha T; Sedono R; Sugiarto A; Pitoyo CW; Paramitha D; Astoro NW; Nasution IR
Acta Med Indones; 2015 Apr; 47(2):136-45. PubMed ID: 26260556
[TBL] [Abstract][Full Text] [Related]
23. Results of a venous thromboembolism prophylaxis program for hospitalized patients.
Cardoso LF; Krokoscz DV; de Paiva EF; Furtado IS; Mattar J; de Souza E Sá MM; de Lira AC
Vasc Health Risk Manag; 2016; 12():491-496. PubMed ID: 28003757
[TBL] [Abstract][Full Text] [Related]
24. The importance of appropriate prophylaxis for the prevention of venous thromboembolism in at-risk medical patients.
Dobesh P
Int J Clin Pract; 2010 Oct; 64(11):1554-1562. PubMed ID: 20846203
[TBL] [Abstract][Full Text] [Related]
25. Interventions for implementation of thromboprophylaxis in hospitalized medical and surgical patients at risk for venous thromboembolism.
Kahn SR; Morrison DR; Cohen JM; Emed J; Tagalakis V; Roussin A; Geerts W
Cochrane Database Syst Rev; 2013 Jul; (7):CD008201. PubMed ID: 23861035
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the two-year outcomes and costs of prophylaxis in medical patients at risk of venous thromboembolism.
Deitelzweig SB; Becker R; Lin J; Benner J
Thromb Haemost; 2008 Nov; 100(5):810-20. PubMed ID: 18989525
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
Spyropoulos AC; Goldin M; Giannis D; Diab W; Wang J; Khanijo S; Mignatti A; Gianos E; Cohen M; Sharifova G; Lund JM; Tafur A; Lewis PA; Cohoon KP; Rahman H; Sison CP; Lesser ML; Ochani K; Agrawal N; Hsia J; Anderson VE; Bonaca M; Halperin JL; Weitz JI;
JAMA Intern Med; 2021 Dec; 181(12):1612-1620. PubMed ID: 34617959
[TBL] [Abstract][Full Text] [Related]
28. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of dalteparin vs unfractionated heparin for the prevention of venous thromboembolism in critically ill patients.
Fowler RA; Mittmann N; Geerts W; Heels-Ansdell D; Gould MK; Guyatt G; Krahn M; Finfer S; Pinto R; Chan B; Ormanidhi O; Arabi Y; Qushmaq I; Rocha MG; Dodek P; McIntyre L; Hall R; Ferguson ND; Mehta S; Marshall JC; Doig CJ; Muscedere J; Jacka MJ; Klinger JR; Vlahakis N; Orford N; Seppelt I; Skrobik YK; Sud S; Cade JF; Cooper J; Cook D; ;
JAMA; 2014 Nov; 312(20):2135-45. PubMed ID: 25362228
[TBL] [Abstract][Full Text] [Related]
30. Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): a pilot cluster randomized trial.
Pai M; Lloyd NS; Cheng J; Thabane L; Spencer FA; Cook DJ; Haynes RB; Schünemann HJ; Douketis JD
Implement Sci; 2013 Jan; 8():1. PubMed ID: 23279972
[TBL] [Abstract][Full Text] [Related]
31. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.
Jacobs BN; Cain-Nielsen AH; Jakubus JL; Mikhail JN; Fath JJ; Regenbogen SE; Hemmila MR
J Trauma Acute Care Surg; 2017 Jul; 83(1):151-158. PubMed ID: 28426561
[TBL] [Abstract][Full Text] [Related]
32. Improved use of thromboprophylaxis for deep vein thrombosis following an educational intervention.
Cohn SL; Adekile A; Mahabir V
J Hosp Med; 2006 Nov; 1(6):331-8. PubMed ID: 17219525
[TBL] [Abstract][Full Text] [Related]
33. Improving the use of venous thromboembolism prophylaxis in an Australian teaching hospital.
Gallagher M; Oliver K; Hurwitz M
Qual Saf Health Care; 2009 Oct; 18(5):408-12. PubMed ID: 19812106
[TBL] [Abstract][Full Text] [Related]
34. Venous thromboembolism prophylaxis conversion in nonsurgical inpatients.
Carroll DN; Hudson EB
Ann Pharmacother; 2003 Sep; 37(9):1194-6. PubMed ID: 12921498
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological Prophylaxis for Venous Thromboembolism Among Hospitalized Patients With Acute Medical Illness: An Electronic Medical Records Study.
Rosenman M; Liu X; Phatak H; Qi R; Teal E; Nisi D; Liu LZ; Ramacciotti E
Am J Ther; 2016; 23(2):e328-35. PubMed ID: 26720163
[TBL] [Abstract][Full Text] [Related]
36. Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population.
Reeves D; Liu CY
J Oncol Pharm Pract; 2010 Mar; 16(1):27-31. PubMed ID: 19401307
[TBL] [Abstract][Full Text] [Related]
37. Defects in Processes of Care for Pharmacologic Prophylaxis Are Common Among Neurosurgery Patients Who Develop In-Hospital Postoperative Venous Thromboembolism.
Yun R; Sciubba DM; Lewin JJ; Streiff MB; Haut ER; Lau BD; Shermock KM; Kraus PS; Popoola VO; Dalpoas SE
World Neurosurg; 2020 Feb; 134():e664-e671. PubMed ID: 31698120
[TBL] [Abstract][Full Text] [Related]
38. International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D; Debourdeau P; Beckers M; Baglin C; Bauersachs RM; Brenner B; Brilhante D; Falanga A; Gerotzafias GT; Haim N; Kakkar AK; Khorana AA; Lecumberri R; Mandala M; Marty M; Monreal M; Mousa SA; Noble S; Pabinger I; Prandoni P; Prins MH; Qari MH; Streiff MB; Syrigos K; Bounameaux H; Büller HR
J Thromb Haemost; 2013 Jan; 11(1):56-70. PubMed ID: 23217107
[TBL] [Abstract][Full Text] [Related]
39. Modification of the National Inpatient Medication Chart improves venous thromboembolism prophylaxis rates in high-risk medical patients.
Yates M; Reddy M; Machumpurath B; Phelps G; Hampson SA
Intern Med J; 2014 Feb; 44(2):190-4. PubMed ID: 24528815
[TBL] [Abstract][Full Text] [Related]
40. Multidisciplinary, patient-centred approach to improving compliance with venous thromboembolism (VTE) prophylaxis in a district general hospital.
Nana M; Shute C; Williams R; Kokwaro F; Riddick K; Lane H
BMJ Open Qual; 2020 Jul; 9(3):. PubMed ID: 32718914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
